Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexins/hypocretins and orexin receptors in apoptosis: a mini‐review
Marc Laburthe, Thierry Voisin, Aadil El Firar
Acta Physiologica (2009) Vol. 198, Iss. 3, pp. 393-402
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
Tian‐Rui Xu, Yang Yang, Richard J. Ward, et al.
Cellular Signalling (2013) Vol. 25, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 142
Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-κB and MAPK signaling pathways in cerebral ischemia/reperfusion injury
Dandan Xu, Tingting Kong, Ziqi Shao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 11, pp. 166230-166230
Open Access | Times Cited: 62
Aberrant Expression of OX1 Receptors for Orexins in Colon Cancers and Liver Metastases: an Openable Gate to Apoptosis
Thierry Voisin, Aadil El Firar, Magali Fasseu, et al.
Cancer Research (2011) Vol. 71, Iss. 9, pp. 3341-3351
Open Access | Times Cited: 87
Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases
Jiao Pang, Chang-Qian Cen, Tian Yuan, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Divergent effects of noradrenergic activation and orexin receptor 1 blockade on hippocampal structure, anxiety-like behavior, and social interaction following chronic stress
Masoumeh Sarfi, Mahmoud Elahdadi Salmani, Taghi Lashkarbolouki, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 250, pp. 173997-173997
Closed Access
The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Toward an Understanding of Agonist Binding to Human Orexin-1 and Orexin-2 Receptors with G-Protein-Coupled Receptor Modeling and Site-Directed Mutagenesis
Alexander Heifetz, Oliver Barker, G. Benjamin Morris, et al.
Biochemistry (2013) Vol. 52, Iss. 46, pp. 8246-8260
Open Access | Times Cited: 42
Study of Human Orexin-1 and -2 G-Protein-Coupled Receptors with Novel and Published Antagonists by Modeling, Molecular Dynamics Simulations, and Site-Directed Mutagenesis
Alexander Heifetz, G. Benjamin Morris, Philip C. Biggin, et al.
Biochemistry (2012) Vol. 51, Iss. 15, pp. 3178-3197
Closed Access | Times Cited: 41
Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice
Anne Blais, Gaëtan Drouin, Catherine Chaumontet, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169908-e0169908
Open Access | Times Cited: 39
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
Alain Couvineau, Stéphanie Dayot, Pascal Nicole, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 32
Orexin-1 Receptor Co-Localizes with Pancreatic Hormones in Islet Cells and Modulates the Outcome of Streptozotocin-Induced Diabetes Mellitus
Ernest Adeghate, Maria J. Fernandez‐Cabezudo, Hameed Rashed, et al.
PLoS ONE (2010) Vol. 5, Iss. 1, pp. e8587-e8587
Open Access | Times Cited: 39
Orexin A Suppresses the Growth of Rat C6 Glioma Cells via a Caspase-Dependent Mechanism
Kaja Biegańska, Paulina Sokołowska, Olaf Jöhren, et al.
Journal of Molecular Neuroscience (2012) Vol. 48, Iss. 3, pp. 706-712
Open Access | Times Cited: 36
The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis
David Alexandre, Coralie Hautot, Marwa Mehio, et al.
European Journal of Cancer (2014) Vol. 50, Iss. 12, pp. 2126-2133
Closed Access | Times Cited: 34
The orexin receptor OX1R in colon cancer: a promising therapeutic target and a new paradigm in G protein‐coupled receptor signalling through ITIMs
Marc Laburthe, Thierry Voisin
British Journal of Pharmacology (2011) Vol. 165, Iss. 6, pp. 1678-1687
Open Access | Times Cited: 33
Expression of Type 2 Orexin Receptor in Human Endometrium and Its Epigenetic Silencing in Endometrial Cancer
Pierre Dehan, C Canon, Geert Trooskens, et al.
The Journal of Clinical Endocrinology & Metabolism (2013) Vol. 98, Iss. 4, pp. 1549-1557
Open Access | Times Cited: 30
Orexin A upregulates the protein expression of OX1R and enhances the proliferation of SGC-7901 gastric cancer cells through the ERK signaling pathway
Yuanyuan Liu, Yuyan Zhao, SHUJING JU, et al.
International Journal of Molecular Medicine (2014) Vol. 35, Iss. 2, pp. 539-545
Open Access | Times Cited: 29
A unified survival theory of the functioning of the hypocretinergic system
Michael H. Chase
Journal of Applied Physiology (2013) Vol. 115, Iss. 7, pp. 954-971
Closed Access | Times Cited: 28
Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A
Nassima Messal, Neïké Fernandez, Stéphanie Dayot, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 11, pp. 3618-3628
Closed Access | Times Cited: 27
In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Oncotarget (2018) Vol. 9, Iss. 6, pp. 6952-6967
Open Access | Times Cited: 25
Orexin-A exacerbates Alzheimer’s disease by inducing mitochondrial impairment
Maoyu Li, Yao Meng, Bingcong Chu, et al.
Neuroscience Letters (2020) Vol. 718, pp. 134741-134741
Closed Access | Times Cited: 21
Advances in prognostic models for osteosarcoma risk
Yi Yao, Dapeng Wang, Zheng Li, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28493-e28493
Open Access | Times Cited: 2
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 44, pp. 7582-7596
Open Access | Times Cited: 16
Intramolecular Fluorescence Resonance Energy Transfer (FRET) Sensors of the Orexin OX1 and OX2 Receptors Identify Slow Kinetics of Agonist Activation
Tian‐Rui Xu, Richard J. Ward, John D. Pediani, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 18, pp. 14937-14949
Open Access | Times Cited: 22
Crucial role of the orexin‐B C‐terminus in the induction of OX1 receptor‐mediated apoptosis: analysis by alanine scanning, molecular modelling and site‐directed mutagenesis
Pascal Nicole, Pierre Couvineau, Nadège Jamin, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 21, pp. 5211-5223
Open Access | Times Cited: 20
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
Alain Couvineau, Nicole Pascal, Gratio Valérie, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4849-4849
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top